Copyright
©2011 Baishideng Publishing Group Co.
World J Hepatol. May 27, 2011; 3(5): 99-107
Published online May 27, 2011. doi: 10.4254/wjh.v3.i5.99
Published online May 27, 2011. doi: 10.4254/wjh.v3.i5.99
Figure 1 Scheme for HCV genotype difference in the molecular pathogenesis of insulin resistance and hepatocarcinogenesis.
HCV: Hepatitis C virus; STAT: Signal transducer and activator of transcription; SOCS: Suppressor of cytokine signaling; mTOR: Mammalian target of rapamycin; PPAR: Peroxisome proliferator-activated receptor; IGFBP: Insulin-like growth factor binding protein; IGF: Insulin-like growth factor; IRS: Insulin receptor substrate; MAPK: Mitogen-activated protein kinase.
- Citation: Kawaguchi T, Taniguchi E, Itou M, Sakata M, Sumie S, Sata M. Insulin resistance and chronic liver disease. World J Hepatol 2011; 3(5): 99-107
- URL: https://www.wjgnet.com/1948-5182/full/v3/i5/99.htm
- DOI: https://dx.doi.org/10.4254/wjh.v3.i5.99